Quantum-Si Expands Proteus Roadshow to Key U.S. and European Markets
Event summary
- Quantum-Si expanded its Proteus roadshow to North Carolina’s Research Triangle Park, St. Louis, and multiple cities in Italy in June 2026.
- The roadshow has already visited Seattle, Houston, Washington D.C., and multiple cities across Germany, France, and the U.K. during Q2 2026.
- The roadshow focuses on educating the market about the Proteus platform and its applications for protein sequencing using the Platinum Pro instrument.
- Jeff Hawkins, CEO of Quantum-Si, emphasized the roadshow's effectiveness in increasing customer awareness of the Proteus technology.
The big picture
Quantum-Si's expansion of the Proteus roadshow underscores its strategic focus on accelerating market education and adoption of its single-molecule protein sequencing technology. This initiative is crucial as the company prepares for the launch of its Proteus platform, aiming to redefine protein analysis. The roadshow's reach into key research and biotech hubs suggests a targeted approach to engaging potential customers and partners, positioning Quantum-Si to capitalize on the growing demand for advanced proteomics solutions.
What we're watching
- Market Adoption
- How the expanded roadshow will affect the pace of Proteus platform adoption in key U.S. and European markets.
- Competitive Positioning
- Whether Quantum-Si can sustain its competitive edge in single-molecule protein sequencing through continued market education.
- Product Launch Readiness
- The pace at which Quantum-Si prepares the market for the Proteus launch following the roadshow.
Related topics